Catalyst Biosciences Inc
CBIO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$525.59M
Close$
$19.85
40.2% upside
Current Fair Value
40.2% upsideUndervalued by 40.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $525.59 Million |
|---|---|
| Enterprise Value | $238.69 Million |
| Earnings per Share | $-14.78 |
| Beta | 1.39 |
| Outstanding Shares | 39,056,224 |
Return
| Return on Equity | -59.14% |
|---|---|
| Return on Assets | -54.16% |
| Return on Invested Capital | -68.66% |
Valuation & Multiples
| P/E Ratio | -2 |
|---|---|
| PEG | - |
| Price to Sales | -14.15 |
| Price to Book Ratio | 2.02 |
| Enterprise Value to Revenue | -9.04 |
| Enterprise Value to EBIT | -1.26 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
-$0.90
Est. -$0.70Revenue
$3.10 M
Est. $625,000Next Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-$0.82
Consensus analyst estimateRevenue Estimate
$416,667
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.42%▼ 51.10% |
|---|---|
| Total Invested | $197.88M▼ 62.30% |
| Investors Holding | 48▼ 34.00% |
About Catalyst Biosciences Inc
CEO: Nassim Usman
